Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose-Ranging Pharmacodynamic Assessment of Platelet Aggregation Inhibition With Clopidogrel in Children of Blalock-Taussig Shunt Age Categories (Neonates and Infants/Toddlers)

NCT00115375 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00115375
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00115375 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose-Ranging Pharmacodynamic Assessment of Platelet Aggregation Inhibition With Clopidogrel in Children of Blalock-Taussig Shunt Age Categories (Neonates and Infants/Toddlers)
Lead sponsor
Sanofi
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2004
Completion date
April 30, 2006
Enrollment
92 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

blood platelet disorders, congenital heart defects